Kindred Capital — 2024 Investments
4 investments dated 2024 · listed companies and verified rows first · show all
Dash Bio is a contract research organization (CRO) offering bioanalysis services with a technology-based, automated approach, delivering sample analysis results in days.
AI & Machine LearningBiotechHealthtechRoboticsBoston, US
Dave Johnson(Co-founder & CEO)inAlexander Tallett(Executive Officer, Director)
BoardAndy Smith(Director)in
Co-investorsCompanion M Gmb HCybernetix VenturesFreestyle CapitalLifeX VenturesOak HC/FTSwift Ventures+1 more
Dunia operates an autonomous laboratory platform that combines physics-informed AI, robotic automation, and a large-scale experimental data engine in a closed-loop Design-Make-Test-Analyze cycle to discover and optimize materials such as electrochemical catalysts.
AI & Machine LearningDeep TechNew Materials
Marcus Tze-Kiat Ng(Founder)in
Co-investorsDeep Science VenturesElaiaPace VenturesThird DerivativeEICredalpine
Fractile designs processors for AI acceleration, offering the next generation of computing hardware.
AI & Machine LearningDeep TechHardwareSemiconductorsBristol, GB
Walter Goodwin(Founder & CEO)in
Co-investors01 AdvisorsAccelFactorial FundsFelicis VenturesGigascale CapitalInovia Capital+10 more
Shift Bioscience develops siRNA therapeutics for cell rejuvenation, using a target identification platform that has identified an anti-fibrotic candidate initially aimed at liver fibrosis.
AI & Machine LearningBiotechLongevityCambridge, GB
Daniel Ives(Founder & CEO)inBrendan Swain(Co-founder & CSO)in
Co-investorsF-Prime CapitalIKJ CapitalCambridge Innovation Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.




















